| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 67028 |
Intravitreal injection of a pharmacologic agent |
24,704 |
21,344 |
$1.94M |
| J0178 |
Injection, aflibercept, 1 mg |
2,812 |
2,616 |
$1.64M |
| J9035 |
Injection, bevacizumab, 10 mg |
11,434 |
9,866 |
$776K |
| 92134 |
|
34,201 |
31,422 |
$521K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
5,986 |
5,778 |
$229K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,782 |
3,695 |
$106K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,629 |
1,596 |
$61K |
| 92250 |
|
2,372 |
2,239 |
$43K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
331 |
327 |
$22K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
317 |
315 |
$21K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
14 |
13 |
$21K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
498 |
485 |
$20K |
| J7999 |
Compounded drug, not otherwise classified |
2,385 |
2,235 |
$19K |
| 92235 |
|
299 |
289 |
$14K |
| 92202 |
|
886 |
865 |
$5K |
| 92226 |
|
227 |
146 |
$5K |
| 67228 |
|
17 |
13 |
$2K |
| 92201 |
|
129 |
125 |
$2K |
| 92225 |
|
23 |
12 |
$588.12 |